Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM News Online.
Press releases published on August 4, 2025
Transocean Ltd. Reports Second Quarter 2025 Results
GlobeNewswire
·
August 4, 2025
Three months ended Three months ended June 30, 2025 March 31, 2025 sequential change June 30, 2024 year-over-year change (In millions, except per share amounts, percentages and backlog) …
Greenlight Re Announces Financial Results for Second Quarter and Six Months Ended June 30, 2025
GlobeNewswire
·
August 4, 2025
Delivers 95.0% Combined Ratio and Returns $5 million to Shareholders Through Buybacks GRAND CAYMAN, Cayman Islands, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Greenlight Capital Re, Ltd. (NASDAQ: GLRE) (“Greenlight Re” or the “Company”) today reported its financial …
Ardelyx Announces Changes to the Executive Leadership Team
GlobeNewswire
·
August 4, 2025
Edward Conner, M.D. appointed Chief Medical Officer and John Bishop, Ph.D. appointed Chief Technical Operations Officer Justin Renz, Chief Financial and Operations Officer, to transition out of the Company WALTHAM, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- …
James River Announces Second Quarter 2025 Results
GlobeNewswire
·
August 4, 2025
PEMBROKE, Bermuda, Aug. 04, 2025 (GLOBE NEWSWIRE) -- James River Group Holdings, Ltd. ("James River" or the "Company") (NASDAQ: JRVR) reported net income from continuing operations available to common shareholders of $3.2 million ($0.07 per diluted share) …
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
GlobeNewswire
·
August 4, 2025
FOSTER CITY, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases …
MercadoLibre Inc., Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 4, 2025
Montevideo, Aug. 04, 2025 (GLOBE NEWSWIRE) -- MercadoLibre, Inc. (Nasdaq: MELI) (http://www.mercadolibre.com) today reported financial results for the second quarter ended June 30, 2025, in a Letter to Shareholders, which is now posted to the company’s …
Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 4, 2025
Company reports strong commercial performance in the second quarter, recording $97.7 million in total revenue, reflecting 33% growth year-over-year IBSRELA generated net sales revenue of $65.0 million; XPHOZAH generated net sales revenue of $25.0 million …
Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia
GlobeNewswire
·
August 4, 2025
First regulatory approval for PYRUKYND in thalassemia, evaluated under SFDA’s Breakthrough Medicines Program Agios partnered with NewBridge Pharmaceuticals, a regional specialty company focused on the Middle East and North Africa, in 2024 to manage …
ISA to Host Seventh Regional Committee Meeting of the Latin America & Caribbean Region in Santiago from 4–6 August
EIN Presswire
·
August 4, 2025
SANTIAGO, CHILE, August 4, 2025 /EINPresswire.com/ -- International Solar Alliance to Host Seventh Regional Committee Meeting in Santiago to Accelerate Solar Innovation and Collaboration Across Latin America …
Biofrontera Inc. to Report Second Quarter FY 2025 Financial Results on August 13, 2025
GlobeNewswire
·
August 4, 2025
Woburn, MA, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc., (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the commercialization of dermatological products, announces it will report financial results for the …
CHC Navigation Introduces NX610 Automated Steering System for Precision Agriculture
EIN Presswire
·
August 4, 2025
CHCNAV launches NX610 Auto-Steer: ±2.5cm GNSS precision, universal vehicle compatibility, and smart farming integration for seamless agricultural efficiency. SHANGHAI, SHANGHAI, CHINA, August 4, 2025 /EINPresswire.com/ -- CHC Navigation (CHCNAV), a …
Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes
GlobeNewswire
·
August 4, 2025
Data Demonstrate that Sana’s Hypoimmune (HIP)-Modified Pancreatic Islet Cells, Transplanted with No Immunosuppression, Persist and Function Over Time in Patient with Type 1 Diabetes Study Establishes Ability to Genetically Modify and Transplant Pancreatic …
Bitget Hosts Crypto Experience Month 2025 Targeting Gen-Zs Across Europe, Asia and Middle East
GlobeNewswire
·
August 4, 2025
VICTORIA, Seychelles, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Bitget, the leading cryptocurrency exchange and Web3 company, officially launches Crypto Experience Month 2025, a global youth activation campaign under its Blockchain4Youth initiative. Now in its …
Freya Pharma Solutions Announces Launch of Phase II Clinical Dose-Response Study testing its LybridoTM Concept Targeting Female Sexual Dysfunction
GlobeNewswire
·
August 4, 2025
www.freyapharmasolutions.com Study evaluates Lybrido™’s Dual-Action therapy for Female Sexual Dysfunction Innovative clitoral blood flow measurement technique aims to objectively quantify treatment efficacy of two dose-combinations ALETTA Pivotal Study …
Osmer Martínez Ramos's Musical Works Under 2025 Latin GRAMMY® Consideration | Obras Aceptadas en el Proceso GRAMMY
EIN Presswire
·
August 4, 2025
Five productions by Osmer Martínez are under 2025 Latin GRAMMY® evaluation | Cinco producciones de La Maquinaria Gaitera en los Latin GRAMMYs 2025. KATY, TX, UNITED STATES, August 3, 2025 /EINPresswire.com/ -- 🇺🇸 ENGLISH VERSION Osmer Martínez Ramos …
AIM ImmunoTech Builds Positive Momentum and Reiterates Focus on Driving Ampligen® Clinical Development Toward Pancreatic Cancer Approval
GlobeNewswire
·
August 4, 2025
Primary focus on pancreatic cancer Mid-year report of Ampligen® (rintatolimod) in combination with AstraZeneca’s Imfinzi® (durvalumab) for the treatment of pancreatic cancer demonstrates positive signs of both no significant toxicity and superior PFS and …
Critical Metals Corp CRML NASDAQ – Announces Exceptionally High Grades of both Gallium & Rare Earth Elements Results at its Tanbreez Project in Greenland
GlobeNewswire
·
August 4, 2025
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading critical minerals mining company, is pleased to report outstanding assay results from recent as well as historical diamond …
Consolidated Water Sets Second Quarter 2025 Investor Conference Call for Tuesday, August 12, 2025 at 11:00 a.m. ET
GlobeNewswire
·
August 4, 2025
GEORGE TOWN, Cayman Islands, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading designer, builder and operator of advanced water supply and treatment plants, will hold a conference call on Tuesday, …
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 4, 2025
RADIANT study with vormatrigine in focal onset seizure (FOS) patients over eight weeks demonstrated 56.3% median reduction in seizure frequency from baseline, with 22% at 100% seizure reduction in last 28 days Initiated two registrational studies for …
Full Alliance Group Launches QUBEE HIVE HOLDINGS to Advance Global Web3 Financial Infrastructure
GlobeNewswire
·
August 4, 2025
TAMPA, Fla., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group, Inc. (OTC: FAGI) today announced the formation of QUBEE HIVE HOLDINGS, INC. (“QUBEE HIVE”), a new subsidiary under Qubitera Holdings, Inc., established to accelerate the Company's global …